Healthcare Cost Trends in New Users of SGLT-2i, DPP-4i and GLP-1 RA for Type 2 Diabetes: An Observational Longitudinal Study
The designation expedites the regulatory review of the drug
3D ) and that GE2 treatment in SD-fed subjects resulted in higher levels of CXCL1 than in WD-fed subjects ( p = 0.034, Cohens d =0.424)
Current Pharmaceutical Design , 2020 In various studies, BPC-157 was observed to: Accelerate healing of muscle, tendon, ligament, nerve, and gut tissue Reduce inflammation, fibrosis, and oxidative stress Protect organ systems (gut, liver, brain) under chemical or surgical stress Stabilize blood vessels and prevent internal bleeding in injury models Importantly, these effects occurred without toxicity , even when administered in high or repeated doses
Lets explore some of these potential advantages: 1
Luo F, Smagris E, Martin SA, Vale G, McDonald JG, Fletcher JA, et al